Infusion devices and methods

Patent metadata

Field	Value
Publication number	US-11508476-B2
Application number	US-202117464304-A
Country	US
Kind code	B2
Filing date	Sep 1, 2021
Priority date	Oct 31, 2006
Publication date	Nov 22, 2022
Grant date	Nov 22, 2022

Abstract

Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.

First claim

The invention claimed is:

1. A glucose monitoring system comprising:
a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly comprising:
an in vivo glucose sensor configured to detect an in vivo glucose concentration of a user, and
a transmitter unit coupled to the in vivo glucose sensor, the transmitter unit configured to generate data indicative of the in vivo glucose concentration,
wherein the first display unit is in data communication with a data management system, and at least the data management system is configured to store the data indicative of the in vivo glucose concentration;
a second display unit in data communication with the data management system for displaying at least a portion of the stored data indicative of the in vivo glucose concentration;
one or more processors of the first display unit coupled with memory of the first display unit, the memory of the first display unit configured to store first instructions that, when executed by the one or more processors of the first display unit, cause the one or more processors of the first display unit to grant a first individual first access level rights to, using the first display unit, modify, set, or lock first level parameters related to the at least a portion of the data indicative of the in vivo glucose concentration; and
one or more processors of the second display unit coupled with memory of the second display unit, the memory of the second display unit configured to store second instructions that, when executed by the one or more processors of the second display unit, cause the one or more processors of the second display unit to grant a second individual second access level rights to, using the second display unit, modify or set second level parameters related to the at least a portion of the data indicative of the in vivo glucose concentration, and
wherein at least a portion of the second level parameters are different than the first level parameters.

2. The glucose monitoring system of claim 1 , wherein the at least the portion of the second level parameters that are different than the first level parameters are locked by the second individual.

3. The glucose monitoring system of claim 1 , wherein the first level parameters include a glucose trend graphical representation.

4. The glucose monitoring system of claim 1 , wherein the first level parameters include an alarm threshold.

5. The glucose monitoring system of claim 1 , wherein the second level parameters include an alarm threshold.

6. The glucose monitoring system of claim 1 , wherein the at least the portion of the second level parameters that are different than the first level parameters include a glucose trend graphical representation, the glucose graphical representation locked by the second individual.

7. The glucose monitoring system of claim 1 , wherein the first level parameters and the second level parameters include a glucose level.

8. The glucose monitoring system of claim 1 , wherein the first level parameters and the second level parameters include a glucose trend arrow.

9. The glucose monitoring system of claim 1 , wherein the first display unit is a first handheld unit.

10. The glucose monitoring system of claim 9 , wherein the first handheld unit is a phone.

11. The glucose monitoring system of claim 9 , wherein the data management system is web-based and accessed through the first handheld unit.

12. The glucose monitoring system of claim 1 , wherein the second display unit is a handheld unit.

13. The glucose monitoring system of claim 12 , wherein the handheld unit is a phone.

14. The glucose monitoring system of claim 12 , wherein the data management system is web-based and accessed through the handheld unit.

15. The glucose monitoring system of claim 1 , further comprising a third display unit in data communication with the data management system for displaying the at least a portion of the data indicative of the in vivo glucose concentration, and
one or more processors of the third display unit coupled with memory of the third display unit, the memory of the third display unit configured to store third instructions that, when executed by the one or more processors of the third display unit, cause the one or more processors of the third display unit to grant a third individual rights to, using the third display unit, modify or set third level parameters related to the at least a portion of the data indicative of the in vivo glucose concentration, and
wherein at least a portion of the third level parameters are different than the first level parameters.

16. The glucose monitoring system of claim 15 , wherein the third level parameters include an alarm threshold.

17. The glucose monitoring system of claim 15 , wherein the at least the portion of the third level parameters that are different than the first level parameters include a glucose trend graphical representation, the glucose trend graphical representation locked by the user.

18. The glucose monitoring system of claim 15 , wherein the at least a portion of the third level parameters are different than the second level parameters.

19. The glucose monitoring system of claim 15 , wherein the third display unit is a handheld unit.

20. The glucose monitoring system of claim 19 , wherein the handheld unit is a phone.

Assignees

• Abbott Diabetes Care Inc

Inventors

• Reggiardo Christopher V
• Kiaie Namvar
• Thomson James

Classifications

• A61M5/31525

  Dosing (burettes, pipettes B01L3/02) · CPC title

• G06F21/30

  Authentication, i.e. establishing the identity or authorisation of security principals · CPC title

• G16Z99/00

  Subject matter not provided for in other main groups of this subclass · CPC title

• G16H40/63 Primary

  for local operation · CPC title

• A61M5/14276

  specially adapted for implantation · CPC title